Evidence map›Paper›PMID 30679249›Full record

ArticleG3 (Bethesda, Md.)2019

Identification of Suppressor of Clathrin Deficiency-1 (

Balaji T Moorthy, Anupam Sharma, Douglas R Boettner, Thomas E Wilson, Sandra K Lemmon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in G3 (Bethesda, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Balaji T MoorthyDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL.
Anupam SharmaDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL.
Douglas R BoettnerDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL.ORCID 0000-0002-0591-443X
Thomas E WilsonDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI.
Sandra K LemmonDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, slemmon@miami.edu.
University of Miami · USUniversity of Michigan–Ann Arbor · US

Funding

SUPPRESSORS OF CLATHRIN DEFICIENCY IN YEASTR01GM055796 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEMMON, SANDRA K. · 1998 to 2015
$4.7M
Systematic Genetic Analysis of Yeast NHEJR01GM120767 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WILSON, THOMAS EDWARD · 2016 to 2025
$2.8M
NIGMS NIH HHS R01 GM055796NIGMS NIH HHS R01 GM120767
6 · The paper itself

Abstract

Clathrin is a major coat protein involved in vesicle formation during endocytosis and transport in the endosomal/trans Golgi system. Clathrin is required for normal growth of yeast

Indexed as

ClathrinEndocytosisGenetic LociReceptors, Cell SurfaceSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsWhole Genome SequencingClathrinEde1 protein, S cerevisiaeReceptors, Cell SurfaceRim21 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsClathrinendocytosismembrane traffickingpooled linkage analysis

Identifiers

PMID30679249
PMCPMC6404604
OpenAlexW2913101305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.